Selinexor ( DrugBank: Selinexor )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
28全身性アミロイドーシス1

28. 全身性アミロイドーシス


臨床試験数 : 267 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04984330
(ClinicalTrials.gov)
December 202129/7/2021Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory DiseaseSelinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory DiseaseAmyloid;Amyloidosis;AL AmyloidosisDrug: Selinexor;Drug: DexamethasoneWeill Medical College of Cornell UniversityKaryopharm Therapeutics IncWithdrawn18 YearsN/AAll0Early Phase 1United States